Linkage Tool: Clinical Trials Fund (CTF) Funding Opportunities

To achieve the goals and objectives of the three CTF funding opportunities through an expedited process, strong connections are essential. One of the ways CIHR is supporting the development of such connections is through this Linkage Tool. The table below provides information submitted by individuals and/or organizations interested in sharing information and/or establishing collaborations in relation to one or more of the three CTF funding opportunities.

Information is provided on a voluntary basis and in no way confers any advantages in the evaluation and/or funding of applications, nor does it replace or constitute a Registration or a Letter of Intent (LOI) to any of the related Funding Opportunities.

To submit your information, please complete the short survey.


Notice

The information is provided in the language in which it was submitted by the respondent.

Contact information Location Stakeholder/
Participant Type
Funding Opportunity of Interest Area(s) of Interest Additional Information
Aurelien Balondona
aurelien@baune.ca
8259010090
Baüne

Alberta

Ontario

Quebec

Industry

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Remote Patient Monitoring Mental eHealth

For more information, please visit Baüne.
Aslam Anis
National Director, CIHR Canadian HIV Trials Network; Director, Centre for Health Evaluation and Outcome Sciences; Professor and Director pro tem, School of Population and Public Health, UBC
aslam.anis@ubc.ca
604-366-8542
CIHR Canadian HIV Trials Network; Centre for Health Evaluation and Outcome Sciences; UBC School of Population and Public Health
The CTN is a national network with headquarters at the Centre for Health Evaluation and Outcome Sciences in British Columbia and several international sites and network affiliations. Independent researcher Platform: Pan-Canadian Clinical Trials Consortium We are interested in connecting with others to collaborate in forming a Clinical Trials Consortium.

The CIHR Canadian HIV Trials Network (CTN) offers expertise in communicable diseases and pandemic preparedness. Our team at the Centre for Health Evaluation and Outcome Sciences (CHÉOS) brings further expertise in non-communicable diseases and policy. Additional context: The CTN is a Canada-wide network that has pioneered 30 years of practice-changing clinical studies and trials to prevent, treat and manage HIV, hepatitis C, other sexually transmitted and blood-borne infections and COVID-19. We are a partnership of researchers, people with lived experience and their caregivers, governments, health advocates and the pharmaceutical and biotechnology industry with 70 affiliated sites across Canada and additional international sites and collaborators. CHÉOS is an interdisciplinary collective founded to pursue excellence in health outcomes research. We produce and translate high-quality research evidence to improve health, transform health systems and provide a wide range of support services for health outcomes research and clinical trial studies.

Gail Tomblin Murphy
Professor, Vice President Research, Innovation & Discovery
gail.tomblinmurphy@nshealth.ca
902-491-5822
Dalhousie University
Nova Scotia

Knowledge User

Independent researcher

Health Professional

Provincial/Territorial Government and Agencies

Platform: Pan-Canadian Clinical Trials Consortium    
Bijoy Menon Professor
bkmmenon@ucalgary.ca
4039448107
University of Calgary
Alberta

Knowledge User

Independent researcher

Health Professional

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Large clinical trials, pragmatic trials, registry linked and e-data linked trials, systems trials, health technology applications, platform trials, acute stroke, imaging. Artificial Intelligence. For more information, please visit Google Scholar.
Maggie McIlwaine
Network Manager
mmcilwaine@cysticfibrosis.ca
6045055715
Cystic Fibrosis Canada

Alberta

British Columbia

Manitoba

New Brunswick

Newfoundland and Labrador

Northwest Territories

Nova Scotia

Nunavut

Ontario

Prince Edward Island

Quebec

Saskatchewan

Yukon

Network covers all Provinces

NGO

Cystic Fibrosis Clinical Trial Network

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Interested in collaborating with other clinical trial networks to form a Clinical Trials Consortium. Respiratory Diseases For more information, please visit Cystic Fibrosis Canada.
Whitney Duff
Clinical Research Lead
ctsu.operations@usask.ca
3069661417
University of Saskatchewan
Saskatchewan

Knowledge User

Academia

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Research infrastructure and support For more information, please visit University of Saskatchewan.
Carmela Tartaglia
MD
carmela.tartaglia@uhn.ca
6479712876
University Health Network
Ontario Independent researcher

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Neurodegenerative disease

Concussion/mild traumatic brain injury

 
John Boyd
Chief Medical Officer
john.boyd@hli.ubc.ca
604 682 2344
Black Tusk Research Group
British Columbia Industry

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

A nimble Site Management Organization with deep expertise in

  1. Database linked bio-specimens including pathogens.
  2. Health Canada Div 5 dossier preparation and submission
  3. Full service (Start-up to close-out) clinical trial support spanning budge and regulatory to coordinator staffing of Phase 1b to 4 trials.
For more information, please visit Black Tusk Research Group.
Susan Fox
sfox@uhnresearch.ca
14166699837
University Health Network
Ontario Health Professional

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

   
Paaladinesh Thavendiranathan
Cardiologist
dinesh.thavendiranathan@uhn.ca
4163405326
Peter Munk Cardiac Center, Toronto General Hospital, University Health Network
Ontario Independent researcher

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Cardiooncology / cardiotoxicity / cardiovascular imaging  
John Kuruvilla
Hematologist / Clinical Investigator
john.kuruvilla@uhn.ca
416 946 2821
Princess Margaret Cancer Centre
Ontario

Knowledge User

Independent researcher

Health Professional

NGO’s

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Lymphoma

Novel therapeutics

Stem Cell transplantation

Cellular Therapy

Translational Research

 
Lillian L Siu
Professor
lillian.siu@uhn.ca
416-946-2911
Princess Margaret Cancer Centre
Ontario Health Professional

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Phase I clinical trials, experimental therapeutics, immunotherapy, biomarkers, cancer, oncology  
Atul Humar
atul.humar@uhn.ca
4163404241
Toronto General Hospital
Ontario Independent researcher      
Philippe Pibarot
Professeur
philippe.pibarot@med.ulaval.ca
5142318534
Université Laval
Quebec Independent researcher Platform: Pan-Canadian Clinical Trials Consortium    
Stephanie Lheureux
Associate Professor as of July 1, 2022
Stephanie.Lheureux@uhn.ca
416-946-2818
Ontario Health Professional Platform: Pan-Canadian Clinical Trials Consortium    
Jordan Feld
Hepatologist, Professor of Medicine
jordan.feld@Uhn.ca
416 340 4584
University Health Network, Toronto Centre for Liver Disease
Ontario

Independent researcher

Health Professional

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Viral hepatitis - hepatitis B, C, D, E

COVID-19

Clinical Trials

Virology

Innate Immunity

Interferon signaling

Viral diagnostics

Chronic liver disease

Wilson Disease

 
Patrick R. Lawler
Doctor
Patrick.Lawler@uhn.ca
416-340-4800 x7183
University Health Network
Toronto, Ontario Health Professional

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

My research aims to develop personalized medicine approaches for the prevention and treatment of cardiovascular disease and critical illness. This work has a strong scientific focus on inflammation and metabolism, is at the intersection between cardiovascular disease and sepsis, and leverages molecular epidemiology/systems medicine approaches in epidemiology and clinical trials. I also have a focus on Bayesian adaptive/platform trials in critical care medicine, and serve on the International Trial Steering Committee of the REMAPCAP global adaptive platform trial (NCT02735707), on the Protocol Development/Leadership Committee for the NIH/NHLBI ACTIV-4 platform trial (NCT04505774), and as co-Principal Investigator of the ATTACC adaptive trial of anticoagulation in hospitalized patients with COVID-19 (NCT04372589) which completed enrollment of 1,204 patients at 62 hospitals in 4 countries. My research is funded by the Canadian Institutes of Health Research and the U.S. National Institutes of Health, among others. For more information, please visit University Health Network.
Michael D. Cusimano
Neurosurgeon and Professor of Neurosurgery
injuryprevention@smh.ca
Alternate email: mountain@smh.ca
416 8645312
Unity Health Toronto-St Michael's Hospital, UHN, Sickkids, University of Toronto, Dhalla Lana School of Public Health, Institute of Medical Sciences, Li Ka Shing Knowledge Institute
Ontario

Knowledge User

Independent researcher

Health Professional

Also interested in technology development and evaluation

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Neurosurgery-related topics, Public Health, Education, Cognition, brain and pituitary tumours, skull base, traumatic brain injury and concussion, injury prevention and surveillance, policy, NPH, SAH, SDH, critical care issues, life course, trigeminal neuralgia, hemifacial spasm, sleep, geospatial, NPH, AI applications, measurement and evaluation, surgical/medical education, technology development  
Andrew Pinto
Doctor
andrew.pinto@utoronto.ca
416-864-6060 x76148
University of Toronto
Ontario Independent researcher

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Primary care, public health, social determinants of health, pragmatic trials, cluster randomized controlled trials, adaptive platform trials

I serve as the lead for clinical research at the U of T primary care practice-based research network (UTOPIAN), and co-lead clinical research for an Ontario-wide network (POPLAR). We have developed a primary care clinical trial network, and interested in pragmatic trials of interventions (medications and vaccines, alternative forms of care, changes in payment, social interventions).

For more information, please visit Upstream Lab.

Alison Orth
Unit Director, Clinical Trials BC
aorth@healthresearchbc.ca
(236) 521-2064
Clinical Trials BC, Michael Smith Health Research BC
British Columbia

Knowledge User

Community Partner

NGO’s

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

We are interested in connecting with others to collaborate in forming a Clinical Trials Consortium and in partnering/collaborating on a training platform.

We are part of the Michael Smith Health Research BC organization which comprises the BC SPOR Support Unit, Clinical Trials BC, Research Ethics BC and funding programs that attract, develop and retain BC‘s health research talent. Our purposes are to strengthen BC‘s health research system by supporting the people, institutions and activities that generate and use research based knowledge to promote, restore and maintain the health of British Columbian’s. We support clinical trial investigator sites and institutions to ensure a world class destination for clinical trials focusing on infrastructure and capacity building. With a collaborative approach we enable clinical trial excellence in the Province of the British Columbia. We have a number of provincial level infrastructure and capacity building programs including a province wide Clinical Trial Management System (CTMS), recruitment platform (REACH BC), quality management system and professional development, mentoring and training programs for clinical trial investigators and team members.

For more information, please visit Clinical Trials BC.

Nishita Singh
Doctor
nishitaneurology@gmail.com
4034373524
University of Calgary
Alberta Health Professional

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

stroke, clinical trials  
Paulo Koeberle
Associate Professor
paulo.koeberle@utoronto.ca
416-786-2894
University of Toronto
Ontario Independent researcher

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Glaucoma, vision loss, blindness, retinal ganglion cell degeneration, stroke, central nervous system injury, brain trauma, retinal degeneration  
Ravi Retnakaran
Professor
Ravi.Retnakaran@SinaiHealth.ca
416-586-4800 ext 3941
Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto; and University of Toronto
Ontario

Independent researcher

Health Professional

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

type 2 diabetes; gestational diabetes; preservation of pancreatic beta-cell function  
Rebecca Barnes
Executive Director
rebecca.barnes@n2canada.ca
Network of Networks (N2)

Alberta

British Columbia

Manitoba

New Brunswick

Newfoundland and Labrador

Northwest Territories

Nova Scotia

Nunavut

Ontario

Prince Edward Island

Quebec

Saskatchewan

Yukon

NGO’s

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

The Network of Networks (N2) is a not-for-profit alliance of Canadian clinical research organizations working to enhance clinical research capability and capacity across all therapeutic areas. N2 provides a pan-Canadian and bilingual platform for delivering training and sharing best practices and resources to ensure efficient and high-quality clinical trials. It is helping to increase the impact of clinical trials through its network capacity in Canada. N2 benefits from the collective expertise of 162 member organizations, representing thousands of clinical research professionals. In addition to its highly-engaged membership, N2 has partnerships with the leading organizations for clinical research stakeholders and experts in Canada.

N2 is Canada’s alliance for excellence in clinical research and the collective national voice for the clinical research community. As it grows and continues to develop new training and resources in direct response to needs voiced by the Canadian clinical research community, it is uniquely positioned to further influence the development of highly qualified personnel (HQP). By building upon the strong foundation N2 has established, including its brand as the national voice, deep and active relationships within the public and private sectors, and broad reach in terms of geography and therapeutic areas, there is an opportunity to drive the activities needed to make Canada a global destination for clinical trials. N2’s envisaged impact areas of particular note include both the earliest part of the clinical research pipeline, by mentoring the next generation of trialists, and the end of the pipeline, by driving more effective knowledge mobilization to help ensure the integration of evidence into decision-making and sharing trial results.

For more information, please visit N2 Canada.

William Scott Beattie
Professor, Department of Anesthesia and Pain
scott.beattie@uhn.ca
16473896927
University of Toronto
Ontario

Knowledge User

Independent researcher

Health Professional

Platform: Pan-Canadian Clinical Trials Consortium

Projects: Clinical Trials

Perioperative Medicine

Pain management

 
Habiballa
Inventor New Drug
habiba011@gmail.com
249961529854
Private Inventor
Sudan

Knowledge User

Independent researcher

Health Professional

Patient

Community Partner

Industry

Provincial/Territorial Government and Agencies

NGO’s

International Organization

Platform: Pan-Canadian Clinical Trials Consortium

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Experimenting with a new clinically discovered drug from herbs. (active ingredient has been identified) (syrup - injection - tablet) Trade name (Stpone Harbel Medicine). It treats a large number of incurable diseases that are related to immunity. 1/ Rheumatoid arthritis 2 / Rheumatoid 3 / Thyroid gland hyper or underactive 4 / Leukemia 5 / carcinoid tumors 7 / wounds caused by diabetes mellitus 9/ Cold infections, including Covid 19 (helps in recovery and no need for drug serums). 10 / Helps restore the menstrual cycle in some cases in which the menstrual cycle is interrupted 11 / Glaucoma is cured within a week The key (modifies the body's immunity) The key to treatment (complete interpretation.....etc)

I started to register it with the FDA and I have a serial number.
Sarvesh Logsettyy
logsetty@umanitoba.ca
204-787-8682
University of Manitoba
Manitoba

Knowledge User

Independent researcher

Health Professional

People: Clinical Trials Fund Training Platforms

Projects: Clinical Trials

Population health, epidemiology, administrative data, clinical trials, injuries, burn injuries, long term outcomes, scar management.  
Date modified: